Word

MOLECULE TO CURE. FAST.

Status

Registered

Status Code

700

Status Date

Tuesday, October 11, 2022

Serial Number

90560241

Registration Number

6868780

Registration Date

Tuesday, October 11, 2022

Mark Type

5000

Filing Date

Thursday, March 4, 2021

Published for Opposition

Tuesday, July 26, 2022

Trademark Owner History

Quotient Sciences Limited - Original Registrant

Classifications

40 Custom manufacture of pharmaceuticals and biopharmaceuticals; custom manufacture of pharmaceuticals and biopharmaceuticals for clinical trial purposes; manufacturing services for clinical trials, namely, manufacture of pharmaceuticals and biopharmaceuticals to order and/or specification of others; providing information about the results of clinical trials for pharmaceutical and biopharmaceutical products, namely, providing technical information in the field of pharmaceutical and biopharmaceutical manufacturing and testing

39 Contract packaging services in the nature of packaging and labeling of pharmaceutical and biopharmaceuticals for distribution on behalf of third parties; packaging and labeling of products for others, namely, contract packaging services in the nature of merchandise packaging for others; storage services, namely, warehousing and temperature controlled storage of goods for others; transportation logistics services, namely, arranging transportation of goods for others; packaging articles to the order and specification of others; packaging of pharmaceutical, biopharmaceutical and clinical supplies and materials, namely, contract packaging services in the nature of pharmaceutical, biopharmaceutical and clinical supplies and materials packaging for others

42 Clinical research in the field of pharmacology and medical research; clinical trials for others; conducting clinical trials for others; conducting clinical trials for others in the field of pharmaceutical and biopharmaceutical products; pharmaceutical and biopharmaceutical research services; pharmaceutical and biopharmaceutical testing services; research relating to science, namely, scientific research, basic and clinical research in the fields of pharmacology, pharmaceuticals and biopharmaceuticals; analytical services, namely, evaluation and analysis of the efficacy of pharmaceutical and biopharmaceutical products and dosages in the nature of analysis and evaluation of pharmaceutical and biopharmaceutical products and dosages to determine conformity with certification standards and to assure compliance with industry standards; pharmaceutical and biopharmaceutical product evaluation; providing medical and scientific research information in the fields of pharmaceuticals, biopharmaceuticals and clinical trials; biological research; research and development of vaccines and medicines; pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical products development; pharmaceutical and biopharmaceutical formulation design and development services, namely, development of pharmaceutical and biopharmaceutical preparations and medicines; pre-formulation screening services, namely, conducting early evaluations in the field of new pharmaceuticals and testing, inspection and research of pharmaceuticals; conducting clinical trials for others for optimisation of pharmaceutical and biopharmaceutical formulations and dosage through clinical testing; development of pharmaceutical and biopharmaceutical preparations and medicines, research and development of vaccines and medicines, product research and development, product development for others, research relating to medicine, namely, medical research, basic and clinical research in the field of pharmacology; consultancy relating to pharmaceutical and biopharmaceutical testing and screening programs in particular testing, inspection and research of pharmaceutical and biopharmaceuticals; consultancy in the field of pharmacology; clinical pharmacology, namely, technical research, testing and consulting in the field of pharmaceutical and biopharmaceutical studies; laboratory research services relating to pharmaceuticals

The mark consists of a word-stacked stylization comprised of the word "Molecule" on top of the words, "to cure". both of which are on top of the word "Fast".

Trademark Events

Oct 11, 2022

Notice Of Registration Confirmation Emailed

Oct 11, 2022

Registered-Principal Register

Jul 26, 2022

Official Gazette Publication Confirmation E-Mailed

Jul 26, 2022

Published For Opposition

Jul 6, 2022

Notification Of Notice Of Publication E-Mailed

Jun 21, 2022

Electronic Record Review Complete

Jun 17, 2022

On Hold - Electronic Record Review Required

Jun 13, 2022

Approved For Pub - Principal Register

May 9, 2022

Teas/Email Correspondence Entered

May 9, 2022

Correspondence Received In Law Office

Apr 29, 2022

Assigned To Lie

Apr 26, 2022

Teas Response To Office Action Received

Oct 29, 2021

Notification Of Non-Final Action E-Mailed

Oct 29, 2021

Non-Final Action E-Mailed

Oct 29, 2021

Non-Final Action Written

Sep 27, 2021

Assigned To Examiner

Jun 3, 2021

New Application Office Supplied Data Entered In Tram

Mar 8, 2021

New Application Entered In Tram